Skip to main content

NeuroMusculoskeletal Institute

Research and Grants

Clinicians and researchers at the NMI are deeply involved in investigations and clinical trials that target advancements in pain management. Most of our patient population has a long-standing relationship with our practice, offering us the abililty to easily connect a large, diverse population to clinical trials.

We work closely with RowanSOM's Clinical Trials Department, which is conveniently located in the same building. The Clinical Trials Department acts as an in-house contract research organization, providing 24-hour support from a nursing staff and departmental coordinator.

Listed below are Dr. Jermyn's research efforts.

Read about the NMI's Efforts to Combat the Opioid Epidemic

Opioid Addiction Prevention Training

Content tailored to specific healthcare professionals

NJCares and NJDCA MODULE 1: Best Practices in Opioid Treatment and Management

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

NJCares and NJDCA MODULE 3: Training for New Jersey Mental Health Professionals

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

NJCares and NJDCA MODULE 5: Comprehensive Review of Medication-Assisted Treatment (MAT) for Substance Use Disorder (SUD)

Module Information and Registration

  • Live Webinar and Enduring Course TBA

 

NJCares and NJDCA MODULE 6: Screening Methodology and Minimizing the Risk of Overdose

Module Information and Registration

  • Live Webinar and Enduring Course TBA

NJCares and NJDCA MODULE 1: Best Practices in Opioid Treatment and Management

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

HRSA Training Modules for Dental Providers

Module Information and Registration
  • Online training for Dental Providers and In-person Training for Students

 

NJCares and NJDCA MODULE 5: Comprehensive Review of Medication-Assisted Treatment (MAT) for Substance Use Disorder (SUD)

Module Information and Registration

  • Live Webinar & Enduring Course TBA

 

NJCares and NJDCA MODULE 6: Screening Methodology and Minimizing the Risk of Overdose

Module Information and Registration

  • Live Webinar and Enduring Course TBA

NJCares and NJDCA Module 1: Best Practices in Opioid Treatment and Management

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

NJCares and NJDCA MODULE 5: Comprehensive Review of Medication-Assisted Treatment (MAT) for Substance Use Disorder (SUD)

Module Information and Registration

  • Live Webinar & Enduring Course TBA

 

NJCares and NJDCA MODULE 6: Screening Methodology and Minimizing the Risk of Overdose

Module Information and Registration

  • Live Webinar and Enduring Course TBA

NJCares and NJDCA Module 1: Best Practices in Opioid Treatment and Management

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

NJCares and NJDCA MODULE 4: Nurses' Role in Addressing New Jersey's Opioid Crisis

Module Information and Registration

  • Live Webinar and Enduring Course TBA

 

NJCares and NJDCA MODULE 5: Comprehensive Review of Medication-Assisted Treatment (MAT) for Substance Use Disorder (SUD)

Module Information and Registration

  • Live Webinar and Enduring Course TBA

 

NJCares and NJDCA MODULE 6: Screening Methodology and Minimizing the Risk of Overdose

Module Information and Registration

  • Live Webinar and Enduring Course TBA

MODULE 2: The Role of Pharmacists in Addressing New Jersey's Opioid Crisis

Module Information and Registration

  • Enduring Course Registration OPEN NOW!
  • Length: 1hr

 

NJCares and NJDCA MODULE 5: Comprehensive Review of Medication-Assisted Treatment (MAT) for Substance Use Disorder (SUD)

Module Information and Registration

  • Live Webinar and Enduring Course TBA

 

NJCares and NJDCA MODULE 6: Screening Methodology and Minimizing the Risk of Overdose

Module Information and Registration

  • Live Webinar and Enduring Course TBA

Research Efforts of Dr. Jermyn

Co-Director, Enhancing First Responder Access to Overdose Treatment in Atlantic County, New Jersey, $500,000, over 4 years, September 2019.

Director, Minority AIDS Initiative for High Risk Men of New Jersey, $500,000, August 16, 2019.

Director, the New Jersey Opioid Medical Education Program (NJ–OMEP,) $941,582.31, over one year, April 15, 2019.

Co–Director, Southern New Jersey Medication Assisted Treatment Center of Excellence (SNJ–MATrx–COE), $2,000,000, March 2019.

Co–Director, Buprenorphine Training Course, SAMHSA, $1,000,000, March 2019.

A Naloxone Training Curriculum for Patients with Opiate Use Disorders to Prevent Fatal Overdose, New Jersey Health Foundation, Grant #PC 46–19 $35,000, February 15, 2019–February 15, 2020.

New Jersey Collaborative to Improve Access to Overdose Treatment, SAMHSA, $923,340 over five years, August 2018.

Opioid Education for Oral Health Workforce and Dental Students Program, HRSA, $399,628 over four years, July 2018.

American Osteopathic Association Cost Effectiveness of OMT, $340,468, May 2018.

New Jersey Opioid Medical Education Program (STORI GRANT), $219,561, January 2018.

New Jersey Geriatrics Workforce Enhancement Program—Opioid Supplemental Funding, July 1, 2018.

Swedish Lottery Award, $100,000 for a music therapy program, ongoing.